RE:RE:RE:RE:RE:RE:i am an american investor Whatever they are paying you, it's far too much as your pumping is pathetic, Realstocky/ Newcamo/ Pandorum/ Moneyman/ marcjohnson (same person pumping). Mid- November now - when is liminal going on Nasdaq? 4th quarter for sure. You've said Ryplazim deal and nasdaq in Q4 since May. Burn is $10M a month and they will receive 30M GBP ($39M USD) on closing of their resin business so added 4 months burn only. Tick tock.
realstocky wrote:
indeed nice to see new faces! hopefully we get a lot of americans on the board. Marc is the first one i know, and we are not even on nasdaq yet.... but soon:: shares will commence trading on the NASDAQ and Toronto Stock Exchange under the new name in the fourth quarter of 2019.
moneyman999 wrote:
welcome also to our new friend from usa, you caught this imo just at the right time, i expect this stock to do a lot better on nasdaq on volumes... you are correct market cap is very attractive if you are a first time buyer of the stock, i expect it to move north a lot next weeks! Good luck
Newcamo wrote:
welcome to lmnl, i also suggest people go to thomvest website https://thomvest.com/portfolio/ and learn what they do, this is all they do, manage businesses like lmnl! They have a lot of experience, knowledge and contacts like at FDA.... selling uk's office to + 77 million$ is a high point up to now, but i expect a lot more shortly, nasdaq, riplazim, and at least 1 indication for pbi , all between this quarter and h1 2020!
marcjohnson wrote:
im american gunner, i dont use stockhouse... but i did take a position in lmnl, so you have me as a guest for at least 4-5 months. Pandorom, im 62, i've seen it all, people that take decisions based upon boards and anonymous posts deserve their fate.
GunnerG wrote: I read the first two sentences and thought this sounds like Pando has another ID. LOL
Sure enough, Nov 6 sign up. Just calling it the Pando group; far to many to list.
marcjohnson wrote: I have been following this for a couple of months, i see the potential upside, market cap is at a level investable, Thomvest is a good manager, they manage in fact several companies like lmnl with an exit point in mind. They will build it up and eventually sell the company to a major which is good for present shareholders at these levels, the opportunity here is interesting. Money in the bank with the latest NR and nasdaq listing before year over with news following (riplazym, pbi). I can see it... i do think americans will like this and buy on nasdaq.